ResMed Inc (RMD)
ResMed Inc. is a common stock listing on the NYSE under the ticker RMD. The company develops, manufactures, distributes, and markets medical devices and cloud-based software used to diagnose, treat, and manage respiratory disorders in the United States and abroad. Its operations are organized into two segments: Sleep and Breathing Health, and Residential Care Software.
Within Sleep and Breathing Health, ResMed provides diagnostic tools and connected care solutions for sleep apnea and related conditions, including portable sleep recorders, a cloud-connected diagnostic device, a sleep lab solution, remote monitoring software, patient engagement applications, and a connectivity module for compatible ventilation devices. Its Residential Care Software segment includes Brightree, HEALTHCAREfirst, MatrixCare, and MEDIFOX DAN, which support providers in home medical equipment, pharmacy, orthotic and prosthetic, home infusion, home health, hospice, skilled nursing, senior living, and residential care. Founded in 1989 and headquartered in San Diego, California, ResMed serves customers in the U.S. and international markets.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-RMD
|
$269.21
|
19.7% Upside
|
Undervalued
|
$247.56
|
10.0% Upside
|
Fair
|
Great
|
September 24, 2026
|
1.2%
|
October 22, 2026
|
21.5x
|
5.0x
|
5.8x
|
32.188 B
|
32.035 B
|
2.5%
|
99.4%
|
12.8
|
23.0%
|
108.3%
|
